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Abstract
Tumorigenesis is a complex process involving numerous cellular signaling
cascades and environmental factors. Here, we report the fabrication of 3D
scaffolds with different morphologies obtained by to study cancer cell proliferation
and migration. Using an FDA approved, biocompatible and biodegradable polymer
Polycaprolactone (PCL), we electrospun nanofiber scaffolds having mesh, aligned,
and honeycomb morphologies. The role of the morphology and cellular
preferences to nutrition in cell adhesion and proliferation was assessed using
scaffolds obtained by electrospinning PCL with fluorescent fructose-like molecular
probes. Cell viability, cell morphology, localized cellular growth as related to
scaffold morphology and availability of the fructose-like molecular probes were
investigated. The changes in biophysical properties of tumor microenvironment
with change in morphology of the scaffolds were observed. In vitro tests for
proliferation, alignment and migration of human dermal fibroblasts (HDFa), normal
breast epithelial cells (184B5), adenocarcinoma (MCF-7), pre-malignant
(MCF10AneoT) and triple-negative (MDA-MB-231 on the scaffolds on days 1, 2,
and 3 were carried out. The morphology of the scaffolds was characterized using
FE-SEM while surface characterization was done using FTIR. Mechanical
properties of the scaffolds were investigated using a Dynamic Mechanical Analyzer
(DMA). Cell proliferation was assessed using CellTiter-Blue® Viability Assay;
migration and cell-scaffold interactions were investigated using phalloidin for FActin. Our data indicates that while topographical features affected cell adhesion
and proliferation, cell lines that responded to the fructose-like probes tended to be
more invasive. Furthermore, the preference to a specific scaffold was greatly
altered by the presence of the probes with MDA-MB-231 showing least preference
after 72 hours and pre-malignant MCF10AneoT showing highest preference.
However, there was no significant difference in the cell numbers between scaffolds
with probes and those without for the pre-malignant cells while this difference was
noticeable in the control cell lines. Hence, a relation between cell preferences,
scaffold morphology and nutritional sources may be sought by further exploring
this approach.

xii

1 Introduction
1.1 Statistics
The Surveillance, Epidemiology and End Results Program (SEER) estimates
about 1.8 million people will be diagnosed with cancer in the United States in 2019
alone [1]. It is also predicted that nearly 50% of these people will be diagnosed
with breast, lung and bronchus, prostate, or colorectal cancers and that these four
cancers will be responsible for roughly 50% of all cancer deaths in 2019 [2]. An
estimated 270,000 men and women will be diagnosed with breast cancer in 2019.
Approximately 12.8 percent of women will be diagnosed with female breast cancer
at some point during their lifetime making it the most common cancer diagnosis in
the US. Fortunately, in its early stages breast cancer is fairly treatable, however in
later stages, after metastasis to distant tissues, the survival rate is only 27.4%
making it an important area of study [3]. The average cost of treatment is between
$20.000 and $100,000 depending on the severity [4] and anywhere from 5 to 10
years of hormone therapy after chemotherapy, radiation or surgery, sometimes all
three [5].

1.2 Defining Cancer
Cancer is defined as a disease which manifests due to mutations in one or
more genes causing uncontrolled cell growth and leading to the formation of a
tumorous mass [6, 7]. The progression, size and location of the tumor defines the
stage of cancer. Stage 0 is typically thought of as cancer free but abnormal cells
with the potential to become cancerous have been found. This is sometimes
referred to as carcinoma in situ cells present in this stage are called premalignant.
Stage I indicates cancer exists in only a small area, this is usually considered early
stage and tumors present are called primary tumors. Larger cancer which has
grown into nearby tissues or lymph nodes are classified as stage II or III. Once the
cancer has spread to distant parts of the body it is considered to have metastasized
and is referred to as advanced or stage IV resulting in the presence of metastatic
cells such as adenocarcinomas [8].

1.3 Current Treatment
Depending on the stage, different treatment options are available for patients.
The National Breast Cancer Foundation offers the following summary of treatment
options for different stages of breast cancer: In the case of a primary tumor, surgery
is usually suggested in order to remove the tumor with a lumpectomy, partial
mastectomy, or radical mastectomy. If it’s deemed necessary, some oncologists
may also prescribe localized radiation and hormone therapy to ensure all
dangerous cells are eradicated. Treatment options vary widely for stage II and III
1

cancers consisting of mastectomy, localized radiation, hormone therapy,
chemotherapy, or in the most successful cases a combination of two or more
treatments. Stage IV indicates the cancer has spread to distant tissues such as
the brain bones, liver and lungs this stage is considered incurable however it has
been shown to respond to a number of treatment options which could extend a
patient’s life several years [9].

1.4 Biology of Cancer
Unfortunately, because every patient is different, there is no one size fits all
treatment option and in too many cases time, money, and resources are spent in
identifying treatment options and may have severe side effects and ultimately may
not work. Investigations into the inner workings of this disease could offer
additional information for combating it. Numerous studies have shown differential
characteristics when comparing the tumor microenvironment to a healthy
physiological microenvironment [10]. Most notably, the tumor microenvironment is
more acidic exhibiting a pH of around 6.8 compared to the more basic physiological
pH of 7.4 [11]. This has been theorized to be due to the hypoxic, or deoxygenated
conditions within a tumor which leads to anaerobic metabolism resulting in
increased levels of acetic acid. The tumor microenvironment is also stiffer than the
surrounding tissues and cancer cells typically have less stiff cellular membrane.

1.5 Our Approach
Since anaerobic metabolism doesn’t yield the same amount of ATP as the
Kreb’s cycle, cancer cells have adapted and shortened the process by taking up
fructose in addition to glucose to obtain a sufficient amount of energy for growth,
proliferation, and metastasis. Fructose is transported to the cells via facilitative
transporters, specifically GLUT5 (SLC2A5). This transporter has not been reported
to be as active in non-cancerous cells [12]. The Warburg effect determined this
affinity to anaerobic metabolism is present even in oxygenated conditions [13]
making exploitation of the GLUT5 pathway using fructose an area of interest.
To examine the behavior of cancer cells and identify better treatment
options in vitro models of the tumor microenvironment have been used. These
models provide a low-cost research platform for cancer therapies, drug screening
and insight on the mechanisms of metastasis by studying the cells in within the
tumor, its stroma, extracellular matrix (ECM) and surrounding signaling molecules.
Current in vitro models such as transwell-based assays monitor cancer cell
migration in response to some stimuli or condition such as chemo attractants, drug
treatments or gene manipulation [14, 15]. These models, although useful with
regards to cancer cell migration and invasion, don’t offer a dynamic environment
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such as that of the tumor microenvironment as the conditions are limited to single
cell migration, invasion and trans endothelial migration in two dimensions.
Spheroids on the other hand are cell aggregates grown in suspension which
closely resemble the spherical nature of a tumor. This makes them more useful for
drug screening, studying immune interactions, and studying tumor growth and
proliferation when compared to 2D cell culture. Sometimes spheroids are grown
embedded in matrix and allows for studies of invasion, matrix remodeling and
angiogenesis. Spheroids embedded in a matrix recapitulate transport properties
cell-cell and cell-matrix interactions between the cells and the tumor
microenvironment [16-18]. Due to their shape larger spheroids sustain oxygen and
nutrient gradients which bear result in the emergence of a necrotic core which bare
similarities to poorly vascularized physiological tumors [19]. Proliferation gradients
have also been demonstrated in spheroid models resulting in protein and gene
expression profiles more closely resembling those of clinical and in vivo gene
expression profiles when compared to 2D culture [20]. These models are more
costly and time consuming when compared to transwell assays. Spheroids also
pose challenges to maintain uniformity and in the case of suspended spheroids
don’t account for the biophysical cues from the ECM.
I hypothesize nanofiber scaffolds composed of FDA approved
biodegradable, biocompatible polymers and designed to offer controllable
biophysical cues would provide a more physiologically accurate in vitro tumor
model than transwell assays or spheroids. I further hypothesize the biochemical
cues present in the tumor microenvironment can be imitated by incorporating
signaling molecules into the scaffolds. The incorporation of fluorescent fructose
probes is expected to offer insight into the metabolism of several cell lines on PCL
nanofiber scaffolds of different topographical morphologies, affecting topotaxis and
durotaxis. We also hope to investigate potential behavior of integrated drugs into
PCL scaffolds.
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2 Materials and Methods
2.1 Fiber Fabrication
2.1.1 Solution Preparation
All polymer solutions dissolved in chloroform were properly labeled and
stirred on a hotplate protected from light at 32°C and 640 RPM (Fisherbrand™
Isotemp™ Stirring Hotplate) to reduce oxidation due to light exposure and prevent
production of phosgene.
2.1.1.1 Polycaprolactone
Polycaprolactone (PCL) is an FDA approved, biodegradable polyester
which has gained a lot of attention for its controllable mechanical properties and
slow degradation rates. Its physiochemical state, chemical and biological
properties, degradability and mechanical strength can all be adjusted allowing it to
be used under harsh mechanical, physical and chemical conditions without
significant loss of its properties.
A solution consisting of 20% PCL (Mw = 70,000 GPC; Scientific Polymer
Products, USA) was prepared in Chloroform HPLC Grade (Sigma Aldrich, USA).
The solution was heated and mixed away from light at 32°C and 640 RPM
(Fisherbrand™ Isotemp™ Stirring Hotplate) until homogeneous.
2.1.1.2 ManCou-H Synthesis
The affinity of breast cancer cells to fructose allowed for the investigation of
their metabolic preferences using fluorescent fructose-like molecules as probes.
The biomedical microdevices lab partnered with Dr. Tanasova’s team in the
chemistry department at Michigan Technological University to test the fructose-like
molecular probe ManCou-H [21-24]. ManCou-H is composed of mannitol with a
coumarin as a fluorescent tag with a hydrogen located in the C4 position.
D-Glucosamine hydrochloride (4.0g, 18.6 mmol, 1.0eq) was dissolved in
water (40 ml) and stirred at room temperature for 5 hours. The solution was then
cooled down with an ice bath. Once cooled, sodium nitrite (3.2g, 46.5 mmol, 2.5eq)
was added followed by portion wise addition of Amberlite 120 H+ (acidic) resin (30
mL). The reaction was then left to stir overnight at 0-4° C. The acidic resin was
then filtration off and the reaction mixture was neutralized with Amberlite IRA-400
basic resin. The solution was then filtered, and the filtrate was dried via
lyophilization to remove water. The desired compound was obtained as a yellow
sicky solid in 79% yield (2.4 g) and was further used without purification (figure
2.1).
4

Figure 2.1 Synthesis of Mannitol using D-Glucosamine HCI the addition of water and
sodium nitrate.
Aldehyde 2 (162.0 mg, 1.0 mmol, 1.0 eq) and 7-aminocoumarin (161.0mg,
1.0 mmol, 1.0 eq) were place into the round bottom flask and dissolved in
MeOH/AcOH solution (10 ml, 95:5 v/v). The reaction mixture was allowed to stir
at room temperature for 30 min. NaBH3CN (3.0 eq) was then added portion wise
(3 x 1.0 mmol) every 30 min and the reaction was allowed to stir at room
temperature overnight (8-10 h). The mixture was then concentrated to dryness
under reduced pressure and subjected to column chromatography. The desired
product was eluted using CH2Cl2: MeOH mixture (9:1 v/v). Samples for biological
testing were further purified on a semi-preparative HPLC using a wateracetonitrile (5->30%) gradient (figure 2.2). The completed molecule with labeled
sections is shown in figure 2.3.

Figure 2.2 Synthesis of Mannitol to Coumarin in order to yield ManCou with a hydrogen
in the functional C4 position.
Yellow solid, 169 mg, 55% yield. 1H NMR (400 MHz, CD3OD): δ, 7.76-7.36
(d, J = 9.2, 1H), 7.32-7.30 (d, J = 8.4, 1H), 6.68-6.65 (dd, J1 = 2.4, J2 = 8.4, 1H),
6.53 (d, J = 2.4, 1H), 6.01-5.99 (d, J = 9.2, 1H), 4.02-3.98 (m, 2H), 3.95-3.92 (m,
1H), 3.88-3.85 (m, 1H), 3.73-3.69 (dd, J1 = 3.2, J2 = 12.0, 1H), 3.66-3.61 (dd, J1 =
5.6, J2 = 12.0, 1H), 3.48-3.44 (dd, J1 = 3.6, J2 = 13.6, 1H), 3.38-3.32 (dd, J1 = 6.8,
J2 = 13.6, 1H) ppm. 13C NMR (100 MHz, CD3OD): δ, 164.7, 158.1, 154.5, 146.5,
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130.2, 112.3, 110.6, 109.1, 98.0, 85.3, 83.2, 80.3, 78.9, 63.3, 46.2 ppm. HRMS
(ESI): m/z [M + Na] + calcd.

Figure 2.3 Complete ManCou-H molecule with coumarin fluorescent component shown
in blue and GLUT5 binding Mannitol component in the black.
2.1.1.3 Polycaprolactone with ManCou-H
To produce biochemically different samples a 20% PCL solution similar to
that described in 2.1.1.2 was mixed with a 20 µM final concentration of ManCouH probe before being sonicated and degassed (Fisher Scientific™ CPXH Series
Digital Ultrasonic Cleaners) for 30 min prior to electrospinning.
2.1.2 Electrospinning
Electrospinning exploits the electric field to draw charged threads of
polymer solutions or polymer melts and continually produce fibers ranging from a
few microns in diameter to ultrathin fibers in tens of nanometers. The
electrospinning process is versatile, and flexible and has the potential to be scaled
up for industrial production. This technique has been shown to have applications
in tissue engineering for scaffold fabrication due to its ability to produce variable
6

fibrous scaffolds repeatedly, including topographies mimicking mesh, aligned and
honeycomb structures similar to those of the natural ECM in the body.
The environmental factors like humidity and temperature, and tip-nozzle
distance and as well as needle diameter were maintained at a constant throughout
the electrospinning process (EM-DIG and EM-RTC; IME Technologies,
Netherlands). These constants were 16% humidity, 70 °F, 17 cm and 0.6 mm,
respectively. The parameters for all morphologies were held constant regardless
of the presence of ManCou-H probe. For the fabrication of scaffolds with mesh
morphologies, a voltage of 11 kV and rotational velocity of 150 RPM with polymer
flow rate of 0.24 mL/hr was used whereas for scaffolds with aligned morphologies,
a similar polymer flow rate and voltage was used with increased rotational speed
of 275 RPM. The honeycomb structured scaffolds were fabricated by
electrospinning at a rotational speed of 300 RPM with a feed rate of 0.18 mL/hr
and applied voltage at the tip of the needle at 10 kV.

2.2 Fiber Characterization
2.2.1 Field Emission Scanning Electron Microscopy (FE-SEM)
Rather than using photons, Field Emission Scanning Electron Microscopy
(FE-SEM) uses electrons liberated from a tungsten field emission source allowing
for visualization of nanometer sized features. Once liberated, these electrons are
accelerated in a high electrical field gradient which produces an ultralow vacuum
environment. Electrons are then focused onto the samples of interest using
electromagnetic lenses and apertures within the column to control the beam.
Images are obtained by collecting electrons scattered by the object under
interrogation on a fluorescent screen or cathode-ray tube (CRT). FE-SEM is
capable of obtaining both backscatter and secondary electron images of
conductive samples and can also be used for energy dispersive spectroscopy
(EDS) for chemical microanalysis. Non-conductive samples must first be sputter
coated with a thin layer of conductive metals most commonly carbon, gold, or
platinum/palladium (Pt/Pd).
FE-SEM is a surface technique which allows for clear and accurate
visualization of nanoscale features making it useful for polymer nanofiber
visualization. To image the topographical morphology of the PCL fibers they were
sputter coated with 5 nm of Pt/Pd. The fibers were then viewed while fixed to pin
stub specimen mounts with carbon tape using an accelerating voltage of 10 kV.
Various magnifications were used to obtain points of interest and the FESEM
(Hitachi S-4700 FE-SEM). Greyscale images were captured and processed using
ImageJ™ to measure the diameter of the nanofibers as well as their directionality
using the ruler and Directionality™ plugin, respectively [25, 26].
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2.2.2 Fourier Transform Infrared Spectroscopy (FTIR)
FTIR or Fourier Transform Infrared Spectroscopy is used to obtain an
infrared spectrum of absorption or emission of a material in solid, liquid or gaseous
state. When infrared light is radiated onto the polymer samples it is absorbed only
when the energy is equal to one of the transitions among the discrete energy levels
of the molecule.
The infrared spectroscopy of the scaffolds was characterized using
Attenuated Fourier Transform Infrared Spectroscopy (Thermo Scientific™,
Nicolet™ iS50 FTIR Spectrometer) from 4000–400 cm-1 at a resolution of 4 cm-1
with 256 scans.
2.2.3 Dynamic Mechanical Analysis (DMA)
Dynamic Mechanical Analysis (DMA) is an instrument which uses a specific
destructive testing technique to measure the physical properties of solids and
polymer melts. It then reports the modulus and damping, and can be programmed
to measure force, stress, strain, frequency and temperature. To use a sample of
known dimensions is loaded onto the clamp holder apparatus, a load is applied,
and the strain is measured. Load displacement can be controlled either by applying
sinusoidal stress and measuring the strain or the load can be increased gradually
to the point of fracture.
The mechanical properties of each scaffold were measured by varying
displacement with respect to time and obtaining stress until failure. The samples
tested measured 0.75 cm in width, the length of each sample was measured by
the DMA and the depth by a screw gauge. Each sample was then exposed to a
stress and the strain was measured while the temperature was held constant at
37°C. Collected data was graphed and analyzed in Origin Pro™ (n=3).
2.2.4 Degradation
The slow degradation of PCL is a major contributing factor for its popularity
in the field of biomaterials. The long degradation rate has led to PCL being used
primarily in the replacement of hard tissues where healing takes longer. However,
it can be extended to engineered soft tissues by decreasing its molecular weight
and degradation time.
Scaffolds with and without ManCou-H probe of each morphology with side
1cm (n = 3) were cut and placed in Phosphate Buffer Solution (PBS) at 37°C. At
time points 1, 2 and 3 hours the PBS was removed and saved at 4°C before being
replaced by new PBS and placed back in the incubator. These samples were then
run through a plate reader (Beckman Coulter DTX 880 Multimode Detector) at 360
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nm excitation and 425 nm emission and concentration of probe leached was
estimated.

2.3 Cell Seeding Experiments
2.3.1 Cell Culture
Adult human dermal fibroblasts (HDFa/ATCC® PCS-201-012™),
adenocarcinoma (MCF7/ATCC® HTB-22™), triple negative malignant cells (MDAMB-231 / ATCC® HTB-26™) and human breast epithelium (184B5 / ATCC® CRL8799™) were purchased from America Type Cell Culture. The premalignant
cancer cell line, MCF-10A-NeoT, was acquired from the Animal Model and
Therapeutics Evaluation Core (AMTEC), Karmanos Cancer Institute, Wayne State
University. Every cell line was maintained at 37°C, at 65% relative humidity, 5%
CO2. All cell lines except MCF-10A-NeoT and 184B5 was maintained in RPMI
1640 culture media supplemented with 10% fetal bovine serum (FBS) and 1%
Penicillin Streptomycin (Pen Strep). MCF-10A-NeoT were cultured in DMEM F12
Ham (1:1) from Gibco with 1.05 mM CaCl2, 10 mM HEPES, 10 µg/mL insulin, 20
ng/mL EGF, 0.5 µg/mL hydrocortisone, 5% horse serum, and 100 ng/mL cholera
toxin. 184B5 was maintained in MEBM supplemented with MEGM Lonza/Clonetics
Corporation kit (Kit Catalog No. CC-3150) minus the GA-1000 (gentamycinamphotericin B mix).
2.3.2 Cell Seeding
Breast cell lines including, 184B5, MCF7, MCF-10A-NeoT, and MDA-MB231 were seeded on scaffolds at a density of 1500 cells per scaffold of side 0.5 cm
for cell viability experiments and scaffolds with dimensions 1.0 x 0.5 cm2 for
immunofluorescent imaging (n=3). The negative control, adult human dermal
fibroblasts, HDFa were seeded at a concentration of 2500 cells per scaffold to
account for the lower rate of proliferation (n=3). Cells were kept in their respective
culture media on nanofiber scaffolds in non-treated tissue culture plates under
standard cell culture conditions. As positive controls, 2500 HDFa cells per well and
1500 cells per well for each of the breast cancer cell lines under test were cultured
on standard tissue culture treated plates.

2.4 Post-Cell Seeding Characterization
2.4.1 Immunostaining
Cells were fixed in 10 mL of 16% methanol-free formaldehyde solution
diluted in 40 mL of PBS to produce a final concentration of 4% paraformaldehyde
and visualized after 1, 2 and 3 days of growth via fluorescence microscopy. The
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cells grown on ManCou-H integrated PCL fibers were stained with Alexa Fluor®
594 Phalloidin (Invitrogen, USA) under TX red filter, with and excitation and
emission of 596 nm and 615 nm, respectively, as well as a DAPI filter, excitation
and emission of 358 nm 461 nm, to illuminate the F-Actin within the cytoskeleton
and the fluorescent fructose mimic, respectively. Cells grown on bare PCL fibers
were also stained with Alexa Fluor® 594 Phalloidin (Invitrogen, USA) and imaged
under the TX red filter but they were also stained with DAPI (4’,6-diamidino-2phenylindole) (Life Technologies, USA) for visualization of F-Actin and the A-T
regions of the nucleus according to manufacturers’ protocol.
2.4.2 Cell Alignment
Cell attachment and alignment along the fibers was quantified using image
analysis software in MATLAB. The built in MATLAB functions for Otsu
thresholding, and watershed were used to segment out the F-actin foreground of
the immunostained images [27]. These segmented images were then run through
another built in MATLAB function called ‘regionprops’ to be analyzed for their area
and orientation [28, 29]. The standard deviation of the alignment orientation of
each detected cell was then compared for each of the segmentation methods
previously described. The average orientation deviation of these values was
plotted using Microsoft Excel.
2.4.3 Cell Viability
The viability of the aforementioned cell lines on scaffolds with sides of
approximately 0.5 cm (n=9) was obtained using CellTiter-Blue® Cell Viability
Assay (Promega, Madison, WI). After 1, 2, and 3 days of growth in 48-wellplates
(CellTreat scientific products®) the culture media was replaced and 20% volume
of CellTiter-Blue® Cell Viability Assay reagent was added followed by 4 hours of
incubation under standard culture conditions (37 °C, 65% RH and 5% CO 2). A
75µL aliquot of the incubated medium was transferred to a clear bottom 96-well
opaque walled culture plate. Cell viability was determined using a plate reader
(Beckman Coulter DTX 880 Multimode Detector) at 560 nm excitation and 590 nm
emission.
2.4.4 Statistical Analysis
Statistical evaluation of the cell proliferation data was done using IBM®
SPSS statistics V25 and OriginPro 2018b. Descriptive statistics was represented
as mean ± standard error of mean (SEM) for cell viability and mean ± standard
deviation (SD) for mechanical characterization of the scaffold. Fibers without
ManCou-H probe were analyzed with one-way ANOVA followed by post-hoc
Tukey’s HSD test to calculate significance at p<0.05 between different days for
each morphology of the scaffold. The same method was used to calculate the
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significance between different cell lines for each morphology of the scaffold. The
same method was used to analyze ManCou-H containing scaffolds.
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3 Results
3.1 Fiber Characterization
By altering the electric field applied, the rotational velocity of the collecting
mandrel, and the fluid flow rate during the electrospinning process three distinct
topographical features were repeatably obtained using the same blend of
polymeric materials. These three topographies are intended to imitate the natural
ECM of various organs within the body. The applied electric field not only
determines the initial elastic stress and bending instabilities in the jet [30], but it
can also be used to control the spatial deposition of the fibers. This ability to control
the spatial deposition is essential for creating topographical features [31]. The
rotational velocity of the rotating mandrel collector helps better control the
alignment, orientation and diameter of the fibers [32]. The applied electric field and
rotational velocity work in conjunction as the applied average electric field
determines the critical rotational velocity [33]. Typically, fibers exhibiting less
alignment are produced using a lower rotational speed for the collector,
alternatively, higher rotational speeds are used to fabricate scaffolds with fiber
orientations perpendicular to the electric field vector. The flow rate at is typically a
key parameter for controlling fiber diameter and distribution [34]. It initiates droplet
shape, controls the trajectory of the jet, and maintains Taylor cone and deposition
area [35, 36]. Higher flow rates result in higher fiber diameters and a higher
deposition area whereas lower flow rates produce thinner fibers with a smaller
deposition area.

Low Magnification
High Magnification

Honeycomb

Aligned

Mesh
A

C

E

B

D

F

Figure 3.1 Field emission scanning electron microscopic (FESEM) images of the PCL
scaffolds exhibiting different morphologies. The low magnification images (A, C, E) are
present on the top while the high magnification images (B, D, F) are present in the bottom.
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Visualization of the scaffolds was done using FE-SEM to analyze fiber
morphology alignment, orientation, and diameter. Three distinct topographies with
and without ManCou-H were initially visually classified as mesh, aligned, and
honeycomb, shown in figure 4A, C and E, and figure 6A, C, and E, respectively.
The lack of beading among all of the fiber scaffolds indicates an ideal concentration
of PCL and chloroform solvent even in the case of fibers containing ManCou-H for
electrospinning [37].

Figure 3.2 The deviation in alignment of the fibers in different morphologies of the bare
scaffolds was characterized using the directionality plugin in ImageJ from the FESEM
images used in figure 3.1 (n=5). The mesh fibers had a high dispersion of fibers in differ
different angles. The aligned fibers had a high concentration of fibers in a narrow angle
range with little amount of deviation in other directions. The honeycomb scaffolds had a
broader range of deviation compared to the aligned scaffold but a much narrower
distribution than the mesh scaffolds. A comparison between the three morphologies helps
to compare the amount of alignment of the fibers and deviation from alignment.
The low magnification image of the mesh scaffolding without ManCou-H,
(figure 3.1A) exhibited randomly oriented fibers which were densely packed
forming a three-dimensional structure as seen by the cells. This dimensionality can
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be seen from the change of contrast shown in the high magnification image shown
in figure 3.1B which indicates the layers. A similar trend can be seen in the
ManCou-H containing fibers shown in figures 3.3A and 3.3B, for low and high
magnification respectively. Upon further analysis using the directionality plugin by
ImageJ these scaffolds exhibited the highest amount of deviation as compared to
the other samples (figure 3.2A and 3.4A). The fiber diameter was determined to
be uniform among the mesh scaffold of 169.7 nm ± 10.7 nm.
Alternatively, the aligned scaffolds were found to have tightly packed fibers
all oriented in the same direction. The deviation from alignment was calculated to
be the lowest among the three morphologies (figure 3.2B and 3.4B). In the low
magnification image (figure 3.3C) the fiber diameter appeared to show regions of
larger and smaller diameter fibers in an alternating manner producing a channel
like effect. The fiber diameter was determined to have a mean of 131.7 nm ± 21.77
nm A high magnification image (figure 3.3D) of the region containing fibers with
larger diameters showed high concentrations of aligned fibers which overlapped
one another to form a tight network.

Figure 3.3 Field emission scanning electron microscopic (FESEM) images of the ManCouH containing PCL scaffolds exhibiting different morphologies. The low magnification
images (A, C, E) are present on the top while the high magnification images (B, D, F) are
present in the bottom.
The low magnification image of the bare and ManCou-H containing
honeycomb scaffolds, shown in figure 3.1E and 3.3E, respectively, shows the
formation of interwoven fibers which interlocked in a specific repeating pattern to
produce elongated, asymmetrical, honeycomb like structures. The arrangement of
the honeycomb structure was characterized to have deep pores which exhibited a
long-range order. Figure 3.1F and 3.3F, the low magnification image of the
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honeycomb structure, shows the boundary of the pores, revealing densely packed
aligned fibers present at the bottom of the pores and densely packed aligned fibers
along the walls. The orientation of these aligned fibers at the wall and the floor of
the pores was different, because of this, when analyzing the orientation there was
a high deviation in alignment more closely related to the mesh morphology than
the aligned despite the densely packed aligned fibers (figure 3.2C and 3C). The
fiber diameter was calculated to have a mean of 144.1 µm ± 47.4 µm According to
a series of experiments done by Bauer and colleagues, the formation of the dense
network helps to mimic the biophysical conditions present during tumor-induced
angiogenesis [38, 39].

Figure 3.4 The deviation in alignment of the fibers in different morphologies of the
scaffolds was characterized using the directionality plugin in ImageJ from the FESEM
images used in figure 3.3 (n=5). The mesh fibers had a high dispersion of fibers in different
angles. The aligned fibers had a high concentration of fibers in a narrow angle range with
little amount of deviation in other directions. The honeycomb scaffolds had a broader range
of deviation compared to the aligned scaffold but a much narrower distribution than the
mesh scaffolds. A comparison between the three morphologies helps to compare the
amount of alignment of the fibers and deviation from alignment.

15

3.2 Chemical Composition
Using ATR-FTIR spectroscopy, the surface characterization of the chemical
bonds on the scaffolds in the absence and presence of ManCou-H was done
shown in figure 3.1 and 3.3, respectively. The different morphologies inferred from
FE-SEM and verified with image analysis using ImageJ showed similar
absorbance intensities from the surface bonds which were extrapolated from
infrared spectroscopy (figure 3.5A and 3.5B). This data cannot be used to draw a
relationship between the isotropic nature of the fibers present in different scaffold
morphologies because the incident beam was focused on a larger surface area
rather than a single nanofiber. The peak seen at 1294 cm-1 is due to the stretching
of C-O and C-C bonds in the crystalline phase [40]. As reported by Wang et. al the
crystalline phase of PCL is accentuated during the electrospinning process[41].
This is due to the application of a high electric field causing the PCL chains to
orient in a single direction [42]. The CH2 vibration and O-C vibrations occur at 732
cm -1 and 961 cm -1 [43, 44], respectively while. bands seen at 1165 cm-1 and 1239
cm-1 correspond to asymmetric and symmetric stretching of the ester COO group
[45]. The peak at 1365 cm -1 is associated with the CH2 band vibrations [46]. The
C=O vibration of ester corresponds to the peak present at 1723 cm -1 [47].
Asymmetric and symmetric stretching of the CH2 group are the cause of the peaks
present at 2865 cm-1 and 2942 cm-1 [48, 49]. Wavenumber where peaks exist
according
to
the
ATR-FTIR
can
be
seen
in
table
3.1.

Figure 3.5 The surface and mechanical characterization of the PCL scaffolds of different
morphologies was done. A) and B) Surface characterization was done using ATR-FTIR
spectroscopy on bare and probe containing fibers, respectively. The peaks distinctive to the
to the molecular bond orientations present in PCL were identified. All the morphologies
had similar surface chemistry.
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Table 3.1 Wavenumber where peaks exist according to ATR - FTIR

Wavenumber (cm-1)

Significant Bonds

2942 cm-1

Asymmetric CH2 stretching

2865 cm-1

Symmetric CH2 stretching

1723 cm-1

C=O stretching of ester

1165 cm-1

C—O stretching

732 cm-1

CH2 vibration

1239 cm-1

Asymmetric C—O—C stretching

1365 cm-1

CH2 bending

961 cm-1

O–C vibrations

1046 cm-1

C—O—C stretching

1294 cm-1

C–O and C–C stretching in the crystalline
phase

3.3 Mechanical Characterization
Mechanical characterization of the scaffolds was done under isothermal
conditions using DMA shown in figure 3.6. Each morphology demonstrated its own
unique stress-strain behavior. The mechanical properties of the probe and nonprobe containing scaffolds are summarized in table 3.2. The honeycomb scaffolds
exhibited the highest average ultimate strength, Young’s modulus, stiffness and
strain at failure as compared to the other two morphologies. The Young’s modulus
and stiffness of the aligned scaffolds was comparable to the honeycomb
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structures; however, the modulus of toughness is lower than that of the honeycomb
scaffolds. As compared to the honeycomb and aligned scaffolds the mesh fiber
morphology has relatively poor strength and toughness. The honeycomb and
aligned scaffolds are ductile while the mesh scaffolds behave more plastically. The
low rotational velocity of the collector and voltage applied during the fabrication
process resulted in the mesh scaffolds elastomeric behavior [50]. Due to the
fundamental truths of their morphology the aligned structures have better
orientation in the microcrystalline regions which increases the Young’s modulus of
the scaffold [51, 52].
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Figure 3.6 The mechanical properties of the scaffolds was characterized using DMA at
isothermal conditions (37°C) and represented as stress-strain graph.
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Table 3.2 Summary of the mechanical properties of the different morphologies of the
scaffold.

3.4 Degradation
The release of the fluorescent probe was quantified at time points 24, 48
and 72 hours using a plate reader. These values were correlated to molarity of
probe release on each day using a calibration curve (figure 3.7). A higher
concentration of probe was shown to be released from the mesh scaffolds on day
1 followed by the mesh and lastly the honeycomb structures. Day 2 showed a
higher release from the mesh scaffolds followed by the aligned then the
honeycomb. Day 3 followed the same trend. This trend is expected as honeycomb
and aligned fibers have a higher surface area resulting in a smaller proportion of
ManCou-H within the scaffold and limiting the available probe to be released. The
estimated amount of probe released for each sample type can be seen in table
3.3. Deviation in release could be the result of non-homogenous mixture of probe
in PCL solution during the electrospinning process causing an uneven distribution
of probe within the scaffold.
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Figure 3.7 Observed drug released from PCL fibers in PBS using ManCou-H probe over
a 3 day period for each fiber morphology the honeycomb values appear to exist below the
deflection limit.
Table 3.3 Drug released from each fiber type measured in nanomolar

Day
1
2
3

Mesh
66.98811
93.92716
38.3986

Aligned Honeycomb
110.5206
-18.7537
62.55685
-10.6373
6.639262
-42.8728

3.5 Immunofluorescent Imaging
Various stages of breast cancer progression were represented by using cell
lines for healthy breast epithelium, adenocarcinoma, premalignant, and triple
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negative / metastatic to evaluate the topotactic behavior of breast cancer cells.
Cells grown on nanofiber scaffolds were stained and fixed 1, 2, and 3 days after
seeding. Cells grown on bare PCL scaffolds were stained for actin in red and
nucleus in blue, however the ManCou-H containing scaffolds were only stained for
actin in red and any blue is due to the ManCou-H probe. Prior to seeding and
staining the scaffolds were tested for to determine whether or not they bound the
stain. It was found that the scaffolds do not express any background absorption of
primary or secondary antibodies indicating the fluorescence seen in the images
are cells. Had Alexa Fluor phalloidin 488 been used for actin staining NucRed™
could have been used to visualize the nucleus while still having the ability to
differentiate the ManCou-H probe.
To get a better idea of how each cell line spans the 1.0x0.5 cm 2 scaffolds
panoramas of the select cells on select scaffolds can be seen in figures 3.8 - 3.12.
The adult human dermal fibroblasts can be seen in figure 3.8 on bare PCL
scaffolds with a honeycomb morphology. Figure 3.9 shows the healthy breast
epithelium on bare PCL scaffolds with a mesh morphology. Figure 3.10 shows
MCF10ANeoT on aligned bare PCL scaffolds. Figure 3.11 shows MCF7 on bare
honeycomb structured PCL scaffolds. Lastly the triple negative adenocarcinoma
can be seen in figure 3.12 on aligned PCL fibers with the ManCou-H probe
integrated into it. Qualitative classification for cell elongation, clumping, alignment
to the scaffolds and infiltration within the scaffold are shown in figure 3.9. Phase
images of fibers can be seen in Appendix A. In the future quantitative assessments
of infiltration will be done using cryosectioning. This was attempted but a protocol
for the cryosectioning of nanofibers is yet to be optimized.
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Figure 3.8 A panorama of adult human dermal fibroblasts on bare PCL scaffolds with a
honeycomb morphology. The nuclei were stained with DAPI shown in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the
blue and red and dispersion by the fibers causes some of the cells to be seem pink in
color. Images captured at 10X magnification.
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Figure 3.9 A panorama of the healthy breast epithelial cell line, 184B5, on bare PCL fibers
with a mesh morphology. The nuclei were stained with DAPI shown in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the
blue and red and dispersion by the fibers causes some of the cells to be seem pink in color.
Images captured at 10X magnification.
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Figure 3.10 A panorama of premalignant cell line, MCF10ANeoT, on bare PCL scaffold
with aligned morphology. The nuclei were stained with DAPI shown in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping of the
blue and red and dispersion by the fibers causes some of the cells to be seem pink in color.
Images captured at 10X magnification.
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Figure 3.11 A panorama of the ductal adenocarcinoma cell line, MCF7, on bare PCL
scaffold with honeycomb morphology. The nuclei were stained with DAPI shown in blue
and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin. The overlapping
of the blue and red and dispersion by the fibers causes some of the cells to be seem pink in
color. Images captured at 10X magnification.
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Figure 3.12 A panorama of the triple negative adenocarcinoma cell line, MDA-MB-231 on
ManCou-H containing PCL fibers with an aligned morphology. The F-actin filaments were
stained with Alexa Fluor® 594 Phalloidin shown in red, the ManCou-H probe is shown in
blue. The overlapping of the blue and red and dispersion by the fibers causes some of the
cells to be seem pink in color. Images captured at 10X magnification.
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Figure 3.13 Phenotypes of the cells on scaffolds used to define cell behavior on the different
morphologies of the scaffold. The phase images show the fibers and the overlaid
fluorescent images show the alignment of nucleus against the orientation of the fibers. A)
Aligned and elongated cells infiltrating into the scaffold. B) Clumped cells on scaffolds C)
Cells aligning along the alignment of the scaffold D) The cells infiltrating through the
different layers of the scaffolds in clumps.
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3.5.1 HDFa

Figure 3.14 Fluorescent microscope images of Human Dermal Fibroblasts (HDFa) on
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days
1, 2 and 3. A) the nuclei were stained with DAPI (blue) B) the probe is in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in
color. Images captured at 10X magnification.
3.5.1.1 HDFa on Bare Scaffolds
The adult human dermal fibroblasts shown in figure 3.14A, maintained an
elongated morphology despite the scaffold topography.
On non-probe containing fiber scaffolds the HDFa’s had little to no cellular
orientation on any morphology on any day. The mesh fiber scaffolds had cell
clumping in specific regions on all days and scaffold infiltration increased from day
1 to day 3. On the aligned scaffolds the cells showed much less clumping on all
days compared to the mesh although they had substantially infiltrated the scaffold
on day 1 and continued to grow within the fibers through days 2 and 3. Cells on
the honeycomb structure showed almost no clumping on day 1 but rather appeared
to be spread out across the scaffold with some infiltration and some cellular
orientation. By day 2 the cells began clumping in the porous regions of the scaffold
with even more infiltration. Definitive cellular orientation is visible on day 3 as well
as significant infiltration into the scaffold.
3.5.1.2 HDFa on ManCou-H Containing Scaffolds
The ManCou-H containing scaffolds (figure 3.14 B) behaved similarly to the
non-probe containing scaffolds in the case of the mesh morphology. The cells are
clumped with no cellular orientation and increasing infiltration from day 1 to day 3.
The cells on the mesh scaffolding look to be interacting with the fructose mimic but
not actively metabolizing it. Cellular orientation on the ManCou-H containing
aligned fibers matched that of the fibers on all days. Scaffold infiltration is high on
day 1 decreasing on day 2 then increasing again by day 3. Cells appear spread
out with almost no clumping on all days. Again, probe can be seen in the vicinity
of the cells, but they do not appear to be taking them up. The cellular orientation
on the honeycomb structures is visible on day 1, ManCou-H appears to be taken
up by the fibroblasts on this day. The HDFa cells infiltrate the scaffold and maintain
orientation on days 2 and 3.
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3.5.2 184B5

Figure 3.15 Fluorescent microscope images of healthy breast epithelium (184B5) on
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days
1, 2 and 3. A) the nuclei were stained with DAPI (blue) B) the probe is in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in
color. Images captured at 10X magnification.
3.5.2.1 184B5 on Bare Scaffolds
Figure 3.15A show images representative of the cell-cell and cell-scaffolds
interactions of healthy breast epithelium, 184B5, on bare and ManCou-H
containing scaffolds, respectively.
On the bare scaffolds the cells appeared to migrate and infiltrate all the
scaffolds on day 1. Cells on mesh scaffolds appeared rounder and flatter on all
days compared to more elongated and aligned morphologies on the honeycomb
and aligned scaffolds. Infiltration of aligned and honeycomb scaffolds is at its
highest on days 2 and 3. Little infiltration can be seen on the mesh scaffolds on all
days. Clumping can be seen on day 3 among all scaffolds.
3.5.2.2 184b5 on ManCou-H Containing Scaffolds
Similar cell-cell and cell-scaffold interactions were observed on the
ManCou-H containing scaffolds on day 1 (figure 3.15B). Clumping on the aligned
and honeycomb scaffolds can be seen on day 2 and excessive clumping was
exhibited on day 3 of the aligned scaffolds. The mesh fibers continued to exhibit
round and flat cells but the elongated morphology of the cells on the aligned and
honeycomb seen on the bare PCL was not as evident on the ManCou-H containing
scaffolds.
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3.5.3 MCF10AneoT

Figure 3.16 Fluorescent microscope images of Premalignant cells (MCF10AneoT) on
different morphologies of B) PCL scaffold with and A) without ManCou-H probe on days
1, 2 and 3. A) the nuclei were stained with DAPI (blue) B) the probe is in blue and the Factin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of
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the blue and red and dispersion by the fibers causes some of the cells to be seem pink in
color. Images captured at 10X magnification.
3.5.3.1 MCF10AneoT on Bare Scaffolds
The analysis of the cell-scaffold interaction of the premalignant cell line,
MCF10AneoT, can be seen in figure 3.16A on bare scaffolds and ManCou-H
containing scaffolds.
The cells on the bare scaffolds tended to clump together on all the
morphologies on all the days. Cells appeared to clump in specific regions and
maintained no cellular orientation on the mesh scaffolds. The aligned scaffolds
exhibited cells which were spread across the scaffold with minimal alignment on
days 1 and 2 then tended to clump on day 3. The cells on the honeycomb structure
were able to infiltrate inside the different layers on day 1. This behavior could also
be seen on day 2 in addition to some clumping. The cells again spread out by day
3 and continued to infiltrate the scaffold compared to days 1 and 2.
3.5.3.2 MCF10AneoT on ManCou-H Containing Scaffolds
The ManCou-H containing scaffold, figure 3.16B resulted in clumping on
day 1 of the mesh scaffolds on days 2 and 3 the cells appeared to spread out and
migrate to distant areas on the scaffold while showing rounded and flattened
morphologies. Clumping was observed on day 2 on the aligned and honeycomb
scaffolds. Probe uptake can be seen on days 1 and 2 of the mesh and aligned
scaffolds and day 2 and 3 on the honeycomb fibers. Uptake was also seen on day
3 of the aligned scaffolds but to a lower extent. The mesh scaffolds showed cells
which appeared to have a more spread out morphology among all days. Cells on
aligned fibers aligned to the fibers to some extent on days 1 and 2 but became
rounder by day 3. The honeycomb structures had cells which appeared both
elongated and rounded at certain regions on all days with extensive scaffold
infiltration.
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3.5.4 MCF7

Figure 3.17 Fluorescent microscope images of Adenocarcinoma cells (MCF7) on different
morphologies of B) PCL scaffold with and A) without ManCou-H probe on days 1, 2 and
3. A) the nuclei were stained with DAPI (blue) B) the probe is in blue and the F-actin
filaments were stained with Alexa Fluor® 594 Phalloidin (red). The overlapping of the
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blue and red and dispersion by the fibers causes some of the cells to be seem pink in color.
Images captured at 10X magnification.
3.5.4.1 MCF7 on Bare Scaffolds
The behavior changes of the adenocarcinoma cell line, MCF7, due to the
various morphologies as well as presence or absence of ManCou-H probe was
qualitatively analyzed by staining the nucleus of cells on bare fibers and the
cytoskeleton of all cells using immunofluorescent staining as was previously
described.
Figure 3.17A illustrates the PCL fibers, these showed cells clumping on day 1
among all three morphologies but most extensive on the aligned scaffolds. The
scaffolds with the mesh morphology showed cells on days 2 and 3 which were
spread out and appeared to have infiltrated the scaffold, this made imaging difficult.
The aligned scaffolds also showed cells spread out on days 2 and 3 however these
cells showed an elongated morphology and were oriented along the direction of
alignment of the fibers. The honeycomb scaffolds had a lot of cell clumping within
the pores of the honeycomb and a very low concentration of cells on the boundary
of the pores on day 2. On day 3 the cells on the honeycomb scaffold infiltrated the
lower layers of the fibers and were present in between the fibers, this can be seen
by the blurred regions between the fibers. Based on their distribution, morphology
and orientation it appears the cells responded to the nano topographical cues
provided by the different morphologies of each scaffold.
3.5.4.2 MCF7 on ManCou-H Containing Scaffolds
Similar trends can be deduced on the ManCou-H containing fibers in figure
3.17B. Probe uptake was observed on all days of the mesh and aligned scaffolds.
Cells remained spread out with no clumping on any scaffold on any day. The mesh
fibers had rounded cells whereas the aligned fibers had cells which aligned with
the scaffold. The honeycomb scaffold showed no uptake of probe and cells varied
from elongated alignment to more rounded morphology

35

3.5.5 MDA-MB-231

Figure 3.18 Fluorescent microscope images of triple negative adenocarcinoma (MDA-MB231) on different morphologies of PCL scaffold with and without ManCou-H probe on
days 1, 2 and 3. On the left the nuclei were stained with DAPI (blue) on the right the probe
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red).
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The overlapping of the blue and red and dispersion by the fibers causes some of the cells
to be seem pink in color. Images captured at 10X magnification.
3.5.5.1 MDA-MB-231 on Bare Scaffolds
Again, using immunofluorescent staining, the interaction between MDAMB-231 cells and the bare scaffolds of different morphology were characterized
(figure 3.18A).
On the mesh scaffolds the cells were distributed throughout without any
logical orientation on days 1, 2 and 3. The cells on the bare aligned morphology
lacked alignment on day 1 but were spread out across the sample, exhibiting little
clumping. The cells on day 2 began to elongate and orient along the direction of
fiber alignment. Cell infiltration into the different layers of the scaffolds can be
deduced on day 3 by the blurred background. The bare honeycomb scaffolds
exhibited little cellular alignment on day 1, but this was improved on day 2. By the
third day in culture the cells infiltrated the scaffolds and attached to the walls of the
honeycomb pores rather than the underlying layers of the fibers. Surprisingly, none
of the morphologies seemed to promote clumping together of cells.
3.5.5.2 MDA-MB-231 on ManCou-H Containing Scaffolds
On the ManCou-H containing scaffolds, figure 3.18B, the triple negative
adenocarcinoma (MDA-MB-231) remained fairly spread out along the scaffold,
only showing slight clumping on day 1 of the honeycomb scaffold. Probe uptake
can be seen on day 2 of the mesh scaffolds. The cells appear to have detached
from the aligned scaffolds on day 2 otherwise maintaining an elongated
morphology oriented along and infiltrated within the scaffold. The mesh scaffolds
exhibited rounded cells on day 1 and 2 but elongated unoriented cells on day 3.
The honeycomb fibers have cells oriented along the fibers with cells exhibiting both
elongated and somewhat rounded cells.

3.6 Cell alignment
3.6.1 Cell Alignment on Bare PCL scaffolds
The deviation of the fibroblasts on the scaffolds of all morphologies was as
expected (figure 3.19A), a high deviation in orientation among the mesh scaffolds
and more alignment, less deviation on the honeycomb and aligned morphologies.
This trend was seen for days 1 and 2 however alignment on the mesh scaffolds on
day 3 appears to be nearly equivalent to that of the honeycomb and aligned
scaffolds, this is likely due to an error in segmentation. The healthy breast
epithelium showed the lowest deviation among the honeycomb samples across all
days with the mesh and aligned scaffold showing similar behavior (figure 3.19B).
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Looking at the premalignant cell line the orientation deviation among the cells
appears to be uniform among all samples except the mesh scaffolds on day 2
which only shows one cell and resulting in a deviation in orientation from other cell
lines of 0 (figure 3.19C). The adenocarcinoma shows similar trends with the lower
deviation in cell orientation among cells on aligned and honeycomb structures
(figure 3.19D). MDA-MB-231 appears to be quite variable, showing better
alignment on the honeycomb structure on day 1 and aligned on day 2 and 3 (figure
3.19E). Additional segmentation methods may need to be implemented in order to
get a better picture of what is happening when cells have clumped.
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Figure 3.19 Cell orientation deviation of all cell lines on all bare morphologies for days 1.
2 and 3. Results were obtained by averaging the directional deviation between cells given
by two different segmentation methods, watershed and Otsu thresholding. The y axis
represents the deviation from the mean orientation of the cells on the scaffolds.
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3.6.2 Cell Alignment on ManCou-H Containing PCL scaffolds
Orientation deviation among the HDFa cell line was minimized on days 2
and 3 on the aligned fibers (figure 3.20A). The honeycomb structures showed the
least deviation on day 1 but the highest deviation on day 3. These results are nearly
opposite to those shown by 184B5 which had the least deviation among the mesh
scaffolds on days 1 and 2, the highest deviation of the honeycomb structures on
days 1 and 2 and the lowest deviation on day 3 (figure 3.20B). The aligned
scaffolds showed the highest deviation on day 3. For the premalignant cell line, the
aligned scaffolds exhibited slightly less deviation among cell orientation, but
deviation is very similar among all morphologies (figure 3.20C). The
adenocarcinoma behaved as would be expected, showing the lowest deviation
among the cells seeded in the aligned fibers followed by the cells on honeycomb
fibers and the highest deviation on the mesh scaffolds on all days (figure 3.20D).
Like the bare scaffolds the MDA-MB-231 behaved variably among all scaffolds,
the aligned showed the lowest deviation on days 1 and 3 (figure 3.20E). Mesh
showed the lowest on day 2 and the highest on day 3.
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Figure 3.20 Cell orientation deviation of all cell lines on all ManCou-H containing
morphologies for days 1. 2 and 3. Results were obtained by averaging the directional
deviation between cells given by two different segmentation methods, watershed and Otsu
thresholding. The y axis represents the deviation from the mean orientation of the cells on
the scaffolds.
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3.7 Cell Viability
3.7.1 Cell Viability on Bare Scaffolds
The cell viability of each cell line on the scaffolds at time points 1, 2 and 3
days was characterized by the reduction of resazurin to resorufin.
On the bare PCL scaffolds, the human dermal fibroblasts exhibited a
significant preference towards the mesh scaffolds peaking at day 1 then appearing
to have a lower metabolic activity on day 2 before increasing again on day 3 (figure
3.21A). These cells otherwise showed an increase in cell number among all other
morphologies among all days. The difference in increased cell number with each
day on aligned morphology was non-significant across all the days. The healthy
breast epithelium showed an increase in cell number across all morphologies of
the scaffolds on all the days (figure 3.21B). The difference in increased cell number
with each day on aligned and honeycomb morphologies was non-significant across
all the days. Scaffolds also demonstrated a significant increase in cell number
among the adenocarcinoma cell line, MCF7, could be seen across all
morphologies of the scaffold on all days (figure 3.21D). Day 3 showed a lower
relative number of viable cells on the positive control when compared to the bare
PCL morphologies. The difference in increased cell number with each day on
positive control was non-significant across all the days. MDA-MB-231 cells
exhibited a statistically significant increase in cell viability over all the days on all
the samples (figure 3.21E). However, the positive control was the most favorable
substrate for the triple negative cell line when compared to the other morphologies.
This is likely due to the stiffness of the positive control, a tissue culture plate, ~10
GPa, which plays a major role in cellular viability as shown by Mah and colleagues
[53]. MCF10AneoT showed less uniform cell viability when compared to the
viabilities of MDA-MB-231 and MCF7 cell lines on all morphologies (figure 3.21C).
A more pronounced increase in cell number is seen from day 1 to day 2 on the
mesh and aligned scaffolds. However, only an increase from day 2 to day 3 on the
honeycomb scaffolds was shown to be significant. The positive control had nonsignificant changes in cell viability among MCF10AneoT cells. The uniform
behavior of the MDA-MB-231 and MCF7 cell lines is present among all
morphologies exhibiting an increase in cell number for all three days.
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Figure 3.21 Quantification of cell viability of bare scaffolds on days 1, 2 and 3 on different
bare morphologies and cell lines. A) Cell viability of HDFa (Human Dermal Fibroblast)
cells on different morphologies of the scaffold. B) Cell viability of 184B5 (healthy breast
epithelium) cells on different morphologies of the scaffold. C) Cell viability of
MCF10AneoT (premalignant) cells on different morphologies of the scaffold. D) Cell
viability of MCF7 (adenocarcinoma) cells on different morphologies of the scaffold. Cells
seeded on mesh scaffold had a significant increase in cell number till day 3. E) Cell viability
of MDA-MB-231 (triple negative) cells on different morphologies of the scaffold. The cell
number increased consistently on all scaffolds till day 3. The increase in cell viability was
inconsistent across any morphology. Error bars represent the standard error of mean and
statistical significance is indicated by p values (*p<0.05)
3.7.2 Cell Viability on ManCou-H Containing Scaffolds
On the ManCou-H containing PCL scaffolds, the HDFa again had a high
cell number on day 1 which dropped on day 2 only to significantly increase again
by day 3. The aligned fibers also showed a significant increase in cell viability
among all days while the honeycomb structures only offered a significant increase
between days 1 and 2 (figure 3.22A). The healthy breast epithelium showed an
increase in cell number across all morphologies of the scaffolds on all the days
(figure 3.22B) indicating a slight preference towards the aligned morphology but
no significant changes were seen between any morphology or any day. The
premalignant cell line showed a similar drop in viability on the mesh fibers from
day 1 to day 2 as HDFa but to a lesser extent (figure 3.22C). A significant increase
in cell viability across all days was seen on the aligned scaffolds. The mesh and
honeycomb scaffolds had a significant increase in cell proliferation from days 2 to
3 with what would appear to be an overall preference towards the honeycomb
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structure. An increase among all morphologies over all 3 days can be seen in the
adenocarcinoma cell line (figure 3.22D). This increase is significant for mesh and
aligned scaffolds among all days but only for days 2 to 3 for the honeycomb
morphology. The MCF7 appeared to prefer the mesh scaffolds to any other
topography. An increase in MDA-MB-231 cell number can again be seen across
all morphologies for the 3-day study. This increase is significant in the mesh
scaffolds from day 1 to day 2 and from day 2 to day 3 on the honeycomb and
aligned morphologies (figure 3.22E).
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Figure 3.22 Quantification of cell viability of ManCou-H containing scaffolds on days 1,
2 and 3 on different morphologies and cell lines. A) Cell viability of HDFa (Human Dermal
Fibroblast) cells on different morphologies of the scaffold. B) Cell viability of 184B5
(healthy breast epithelium) cells on different morphologies of the scaffold. C) Cell viability
of MCF10AneoT (premalignant) cells on different morphologies of the scaffold. D) Cell
viability of MCF7 (adenocarcinoma) cells on different morphologies of the scaffold. Cells
seeded on mesh scaffold had a significant increase in cell number till day 3. E) Cell viability
of MDA-MB-231 (triple negative) cells on different morphologies of the scaffold. The cell
number increased consistently on all scaffolds till day 3. The increase in cell viability was
inconsistent across any morphology. Error bars represent the standard error of mean and
statistical significance is indicated by p values (*p<0.05)
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3.8 Discussion
Topographical features and mechanical properties of the scaffolds were
shown to influence the cell viability, cell-cell interaction and cell-scaffolds behavior.
The adenocarcinoma, MCF7, cells proliferated well in all tested without much
preference towards any particular topographical morphology. These findings are
supported by the work of Chaudhuri et al. on the inhibition of Rho-ROCK-Myosin
signaling in malignant cells leading to the proliferation of adenocarcinoma
irrespective of the topography [23]. The cells did tend to prefer elastomeric
scaffolds with low Young’s modulus and stiffness such as the mesh scaffolds over
scaffolds with higher Young’s modulus and stiffness like the honeycomb and
positive control. This agrees with several experimental investigations on MCF7
including Li et. al on the mechanical properties of breast cancer cells through
atomic force microscopic measurements and [54] and durotaxis studies performed
by Cavo et. al [55].
Alternatively, the triple-negative cell line tended to thrive on scaffolds with a
stiffer matrix, this was expected due to the regulation of the YAP (Yes associated
protein)/TAZ (transcriptional coactivator with PDZ-binding motif) followed by the
activation of the Hippo cascade [56]. Topotactic and durotactic gradients guided
the cellular alignment and infiltration on the honeycomb and aligned scaffolds
which demonstrated extensive cellular infiltration as well as alignment. Lin et. al
reported the stiffness of scaffolds positively enhances the migration potential of
metastatic cells [57] and can drive tumor progression through a TWIST1-G3BP2
mechanotransduction pathway [58]. The premalignant cells preferred the aligned
scaffolds as they appeared to allow the cells to infiltrate and orient along the fibers.
The aligned fibers provide topographical cues which aid in the cell spreading due
to migration and can also impact tumor progression and metastasis [59].
A certain amount of cell clumping was reported on all morphologies, this is
in direct correlation of the metastatic potential of the cells. The metastatic potential
of the cells indicates the clumped cells form protrusions followed shortly after by
invasion [60, 61]. Observations made by Rubashkin et. al are consistent with
increased viability and spreading of premalignant cells in stiffer scaffolds [62].
Additionally, there did not appear to be much preferential difference in cell
attachment, migration or proliferation between ManCou-H and non ManCou-H
containing scaffolds. With the lack of nutrition offered by the fructose mimic it was
expected that the cancerous cell lines would take up the probe via GLUT5 and die
off. Alterations in this expectation could be due to the minimal amount of probe
released in such a short time as shown by the degradation studies. The optimal
concentration of ManCou-H within the scaffold may yet need to be determined.
For these reasons, it can be concluded that the cells respond to changes
in scaffolds topography and mechanical properties based on the stage of cancer.
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This indicates an in vitro tumor model which takes topotaxis and durotaxis into
account would be suitable. Such a scaffold can provide the ideal platform for
studying breast cancer metastasis or for localized therapy to inhibit the growth of
metastatic cells. The efficient electrospun scaffold design also allows the scaffold
system to be easily adapted for the study and treatment of other cancers through
the respective topotactic gradients [63].
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4 Conclusion
Different topotaxic and durotaxic features can be incorporated into 3D
scaffolds via Polycaprolactone (PCL) electrospinning. These scaffolds have been
shown to have similar surface chemistry yet when cancer cell lines of various
malignancies were seeded behavior changes were apparent. Adenocarcinoma,
triple negative, and premalignant breast cancer cell lines were seeded on
nanofiber scaffolds of different morphologies in the presence and absence of
fluorescent fructose mimics, ManCou-H. Using healthy breast epithelium and
human dermal fibroblasts as controls, the cell-cell and cell-scaffold interactions
were qualitatively analyzed using immunofluorescent staining and quantitatively
analyzed for their cell viability over a period of 3 days.
Human dermal fibroblasts proliferated more highly on mesh scaffolds
followed closely by the positive control, both which exhibited a low elastic modulus.
This was the case in the presence and absence of the ManCou-H probe. Cell
alignment to the scaffold appeared to be more prevalent in the fibroblasts
compared to other cell lines. Cells showed favorable alignment along these
scaffolds. The adenocarcinoma cells also proliferated more highly on mesh
scaffolds which exhibited a low elastic modulus similar to the HDFa.
Healthy breast epithelium showed high variability, not seeming to prefer any
one morphology on the bare fibers yet showing preference to the higher stiffness
of the aligned and honeycomb structures. Despite these preferences the cells still
appeared to have little alignment due to excessive clumping. The premalignant cell
line preferred a more aligned morphology which had a high stiffness and more
contact guidance when on PCL scaffolds without the ManCou-H. In the presence
of ManCou-H this preference shifted more towards the honeycomb morphology
which exhibited slightly less contact guidance.
For PCL fibers which did not contain ManCou-H the triple negative cell line
appeared to exhibit a slight preference to the honeycomb scaffolds with higher and
strength as indicated by the cell viability as well as the immunofluorescent staining.
In the presence of the ManCou-H, MDA-MB-231 appeared to shift its preference
to the aligned morphology with the mesh and honeycomb not far behind.
It was found that these scaffolds were able to mimic the mechanical and
topographical tumor microenvironment by providing biophysical signals for
topotaxis and durotaxis. These scaffolds were also able to provide information on
the molecular uptake behavior of cells on various topographies. Changes in uptake
altered the cell-cell and cell-scaffold interactions on similar topographies.
It was also noted that the cancerous cell lines aligned more readily with the
aligned scaffolds by day 3 on the bare PCL scaffolds, when compared to the noncancerous controls. This trend was not the same in the presence of the ManCou52

H probe. The cancerous cell lines still showed a high alignment to the aligned
scaffolds on day 3 but to a much smaller capacity. The MCF10ANeot showed
similar deviation among all scaffolds. Furthermore, the HDFa exhibited high
alignment on day 3 of the aligned scaffolds in the presence of the probe compared
to the absence.
These differential preferences towards topographical features indicate not only
the benefit of using nanofiber scaffolds as platforms to model breast cancer but
also the feasibility to design a nanofiber scaffold capable of attracting and trapping
metastasizing cancer cells. Further studies will also be done to optimize the probe
concentration within the scaffolds to offer a better understanding for the slow
release of drugs or chemokines from PCL platforms.
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5 Future Work
Protein analysis through western blot would indicate what is happening within
the cell with regards to upregulation and downregulation of specific pathways.
Further investigation into preferences of different cancer cell lines such as small
cell carcinoma, and kidney cancer would allow for potential expansion into
relevance in all cancers. All of this research is currently underway to potentially
lead to an engineered scaffold with controllable stiffness, structure and shape, in
order to combat cancerous cells within the body as a cancer trap or outside of the
body as a research platform for multiple types of cancer.
Based on the response observed for cancer cells on scaffolds with the
fructose-like molecular probe, the concentration, availability and the time of cell
interaction with the probe should be optimized. Since there is also a cell-line
dependent preference towards scaffolds, the probe optimization will also need to
incorporate scaffold morphology. Future studies will include direct comparison with
fructose in the scaffolds.
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6 Appendix
A. HDFa on Bare PCL Fibers
Aligned

Mesh

Honeycomb

Aligned

Honeycomb

Day 3

Day 3

Day 2

Day 2

Day 1

Day 1

Mesh

B. HDFa on ManCou-H Containing PCL Fibers

400 µm

400 µm

Figure 6.1 Fluorescent microscope images of human dermal fibroblasts (HDFa) on
different morphologies of the PCL scaffold with and without ManCou-H probe on days 1,
2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the
F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The images were
overlaid with the phase contrast image to provide additional information about the scaffold
morphology. The overlapping of the blue and red and dispersion by the fibers causes some
of the cells to be seen pink in color. Images captured at 10X magnification.
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Figure 6.2 Fluorescent microscope images of healthy breast epithelium (184b5) on
different morphologies of the PCL scaffold with and without ManCou-H probe on days 1,
2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the
F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red). The images were
overlaid with the phase contrast image to provide additional information about the scaffold
morphology. The overlapping of the blue and red and dispersion by the fibers causes some
of the cells to be seen pink in color. Images captured at 10X magnification.
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A. MCF10ANeoT on Bare PCL Fibers
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Figure 6.3 Fluorescent microscope images of premalignant breast cancer cells
(MCF10AneoT) on different morphologies of the PCL scaffold with and without ManCouH probe on days 1, 2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red).
The images were overlaid with the phase contrast image to provide additional information
about the scaffold morphology. The overlapping of the blue and red and dispersion by the
fibers causes some of the cells to be seen pink in color. Images captured at 10X
magnification.
A. MCF7 on Bare PCL Fibers
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Figure 6.4 Fluorescent microscope images of adenocarcinoma cells (MCF7) on different
morphologies of the PCL scaffold with and without ManCou-H probe on days 1, 2 and 3.
In A) the nuclei were stained with DAPI (blue) in B) the probe is in blue and the F-actin
filaments were stained with Alexa Fluor® 594 Phalloidin (red). The images were overlaid
with the phase contrast image to provide additional information about the scaffold
morphology. The overlapping of the blue and red and dispersion by the fibers causes some
of the cells to be seen pink in color. Images captured at 10X magnification.

56

A. MDA-MB-231 on Bare PCL Fibers
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Figure 6.5 Fluorescent microscope images of triple negative adenocarcinoma cells (MDAMB-231) on different morphologies of the PCL scaffold with and without ManCou-H
probe on days 1, 2 and 3. In A) the nuclei were stained with DAPI (blue) in B) the probe
is in blue and the F-actin filaments were stained with Alexa Fluor® 594 Phalloidin (red).
The images were overlaid with the phase contrast image to provide additional information
about the scaffold morphology. The overlapping of the blue and red and dispersion by the
fibers causes some of the cells to be seen pink in color. Images captured at 10X
magnification.
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